131 related articles for article (PubMed ID: 38039406)
1. Therapeutic potentials and challenges of cytostatic persister cancer cells.
Kim PY; Leung CT
Oncotarget; 2023 Dec; 14():944-945. PubMed ID: 38039406
[No Abstract] [Full Text] [Related]
2. Sustained Oncogenic Signaling in the Cytostatic State Enables Targeting of Nonproliferating Persistent Cancer Cells.
Kim LM; Kim PY; Gebreyohannes YK; Leung CT
Cancer Res; 2022 Sep; 82(17):3045-3057. PubMed ID: 35792658
[TBL] [Abstract][Full Text] [Related]
3. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells.
Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H
J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785
[TBL] [Abstract][Full Text] [Related]
4. Effects of MicroRNA-19b on the Proliferation, Apoptosis, and Migration of Wilms' Tumor Cells Via the PTEN/PI3K/AKT Signaling Pathway.
Liu GL; Yang HJ; Liu B; Liu T
J Cell Biochem; 2017 Oct; 118(10):3424-3434. PubMed ID: 28322459
[TBL] [Abstract][Full Text] [Related]
5. miR-21 regulates the proliferation and apoptosis of ovarian cancer cells through PTEN/PI3K/AKT.
Liu HY; Zhang YY; Zhu BL; Feng FZ; Yan H; Zhang HY; Zhou B
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4149-4155. PubMed ID: 31173285
[TBL] [Abstract][Full Text] [Related]
6. JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer.
Qiu H; Li J; Clark LH; Jackson AL; Zhang L; Guo H; Kilgore JE; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2016 Oct; 7(41):66809-66821. PubMed ID: 27572308
[TBL] [Abstract][Full Text] [Related]
7. F-box and leucine-rich repeat protein 5 promotes colon cancer progression by modulating PTEN/PI3K/AKT signaling pathway.
Yao H; Su S; Xia D; Wang M; Li Z; Chen W; Ren L; Xu L
Biomed Pharmacother; 2018 Nov; 107():1712-1719. PubMed ID: 30257389
[TBL] [Abstract][Full Text] [Related]
8. SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway.
Liu C; Wu H; Li Y; Shen L; Yu R; Yin H; Sun T; Sun C; Zhou Y; Du Z
J Neurooncol; 2017 Nov; 135(2):263-272. PubMed ID: 28887597
[TBL] [Abstract][Full Text] [Related]
9. MiR-21 inhibitor suppressed the progression of retinoblastoma via the modulation of PTEN/PI3K/AKT pathway.
Gui F; Hong Z; You Z; Wu H; Zhang Y
Cell Biol Int; 2016 Dec; 40(12):1294-1302. PubMed ID: 27600360
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-214 acts as a potential oncogene in breast cancer by targeting the PTEN-PI3K/Akt signaling pathway.
Wang F; Li L; Chen Z; Zhu M; Gu Y
Int J Mol Med; 2016 May; 37(5):1421-8. PubMed ID: 26951965
[TBL] [Abstract][Full Text] [Related]
11. AKT inhibition by triciribine alone or as combination therapy for growth control of gastroenteropancreatic neuroendocrine tumors.
Gloesenkamp CR; Nitzsche B; Ocker M; Di Fazio P; Quint K; Hoffmann B; Scherübl H; Höpfner M
Int J Oncol; 2012 Mar; 40(3):876-88. PubMed ID: 22075556
[TBL] [Abstract][Full Text] [Related]
12. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
Fang J; Ding M; Yang L; Liu LZ; Jiang BH
Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
[TBL] [Abstract][Full Text] [Related]
13. PI3K/Akt and Stat3 signaling regulated by PTEN control of the cancer stem cell population, proliferation and senescence in a glioblastoma cell line.
Moon SH; Kim DK; Cha Y; Jeon I; Song J; Park KS
Int J Oncol; 2013 Mar; 42(3):921-8. PubMed ID: 23314408
[TBL] [Abstract][Full Text] [Related]
14. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
[TBL] [Abstract][Full Text] [Related]
15. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
Zuo WN; Zhu H; Li LP; Jin AY; Wang HQ
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418
[TBL] [Abstract][Full Text] [Related]
16. PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells.
Ma J; Sawai H; Ochi N; Matsuo Y; Xu D; Yasuda A; Takahashi H; Wakasugi T; Takeyama H
Mol Cell Biochem; 2009 Nov; 331(1-2):161-71. PubMed ID: 19437103
[TBL] [Abstract][Full Text] [Related]
17. Jolkinolide B attenuates laryngeal cancer cell growth and induces apoptosis via PTEN/PI3K/Akt signaling pathway.
Dong L; Liu F; Liu D; Kang S; Yang X; Wang J
In Vitro Cell Dev Biol Anim; 2021 Sep; 57(8):786-794. PubMed ID: 34697781
[TBL] [Abstract][Full Text] [Related]
18. Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migration of human melanoma cells and elicits PTEN elevation and inactivation of PI3K/AKT signaling.
Foster JS; Fish LM; Phipps JE; Bruker CT; Lewis JM; Bell JL; Solomon A; Kestler DP
BMC Cancer; 2013 May; 13():227. PubMed ID: 23648148
[TBL] [Abstract][Full Text] [Related]
19. Loss of PDZK1 expression activates PI3K/AKT signaling via PTEN phosphorylation in gastric cancer.
Zhao C; Tao T; Yang L; Qin Q; Wang Y; Liu H; Song R; Yang X; Wang Q; Gu S; Xiong Y; Zhao D; Wang S; Feng D; Jiang WG; Zhang J; He J
Cancer Lett; 2019 Jul; 453():107-121. PubMed ID: 30930234
[TBL] [Abstract][Full Text] [Related]
20.
Lu XX; Cao LY; Chen X; Xiao J; Zou Y; Chen Q
Biomed Res Int; 2016; 2016():2476842. PubMed ID: 27822469
[No Abstract] [Full Text] [Related]
[Next] [New Search]